Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of the National Cancer Institute

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/jnci/djv017PMID 25710962PMCID PMC4402365
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer.

  2013influential reference
• Combining two strategies to improve perfusion and drug delivery in solid tumors

  2013cited by this paper
• Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels

  2013cited by this paper
• Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients

  2013cited by this paper
• Benefits of vascular normalization are dose and time dependent--letter.

  2013cited by this paper
• The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer.

  2013cited by this paper
• Augmented Macrophage Differentiation and Polarization of Tumor-associated Macrophages Towards M1 Subtype in Listeria-administered Tumor-bearing Host

  2012cited by this paper
• TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma

  2012cited by this paper
• Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer

  2012cited by this paper
• Macrophages in Tumor Microenvironments and the Progression of Tumors

  2012cited by this paper
• Mouse forestomach carcinoma cells immunosuppress macrophages through transforming growth factor-β1

  2012cited by this paper
• NIH Image to ImageJ: 25 years of image analysis

  2012cited by this paper
• Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors

  2012cited by this paper
• Inhibition of matrix metalloproteinase‐2 improves endothelial function and prevents hypertension in insulin‐resistant rats

  2012cited by this paper
• Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis.

  2011cited by this paper
• Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors.

  2011cited by this paper
• Obligatory role of heat shock protein 90 in iNOS induction.

  2011cited by this paper
• Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

  2011cited by this paper
• Normalization of the vasculature for treatment of cancer and other diseases.

  2011cited by this paper
• TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo

  2011cited by this paper
• TGF-β receptor signaling pathways in angiogenesis; emerging targets for anti-angiogenesis therapy.

  2011cited by this paper
• Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

  2011cited by this paper
• Molecular mechanisms and clinical applications of angiogenesis

  2011cited by this paper
• Glioma cancer stem cells induce immunosuppressive macrophages/microglia.

  2010cited by this paper
• Matrix metalloproteinases: regulators of the tumor microenvironment.

  2010cited by this paper
• Activated macrophages as a novel determinant of tumor cell radioresponse: the role of nitric oxide-mediated inhibition of cellular respiration and oxygen sparing.

  2010cited by this paper
• Stromal regulation of vessel stability by MMP14 and TGFβ

  2010cited by this paper
• Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.

  2009cited by this paper
• Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging

  2009cited by this paper
• Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

  2009cited by this paper
• PGE2 induces angiogenesis via MT1-MMP-mediated activation of the TGFbeta/Alk5 signaling pathway.

  2008cited by this paper
• Pharmacoproteomics of a Metalloproteinase Hydroxamate Inhibitor in Breast Cancer Cells: Dynamics of Membrane Type 1 Matrix Metalloproteinase-Mediated Membrane Protein Shedding

  2008cited by this paper
• Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy

  2007cited by this paper
• The role of nitric oxide in tumour progression

  2006cited by this paper
• Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.

  2006cited by this paper
• The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis

  2006cited by this paper
• Inducible nitric oxide synthase subserves cholinergic vasodilation in retina

  2005cited by this paper
• Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

  2004cited by this paper
• Interferon-gamma cooperates with Helicobacter pylori to induce iNOS-related apoptosis in AGS gastric adenocarcinoma cells.

  2004cited by this paper
• Reversal of Tumor-induced Immunosuppression by TGF-β Inhibitors

  2003cited by this paper
• Reversal of tumor-induced immunosuppression by TGF-beta inhibitors.

  2003cited by this paper
• Matrix metalloproteinase inhibitors (MMPIs): The beginning of phase I or the termination of phase III clinical trials

  2003cited by this paper
• Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

  2002cited by this paper
• Development of matrix metalloproteinase inhibitors in cancer therapy.

  2001cited by this paper
• Matrix metalloproteinase inhibitors: past lessons and future prospects in breast cancer.

  2001cited by this paper
• Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis.

  1999cited by this paper
• Inducible nitric oxide synthase and the regulation of central vessel caliber in the fetal rat.

  1996cited by this paper
• Review Article Transforming Growth Factor-beta and Matrix Metalloproteinases: Functional Interactions in Tumor Stroma-infiltrating Myeloid Cells

  year unknowncited by this paper

• Spatiotemporal dynamics of radioresistance: decoding macrophage-driven radioprotective niches through temporal-spatial reprogramming.

  2026cites this paper
• Targeting Matrix Stiffness and Mechanotransduction in Breast Cancer: Implications for Emerging Therapies

  2026cites this paper
• Matrix Metalloproteinase 14 in Corneal Neovascularization.

  2026cites this paper
• VPS35/Retromer-dependent MT1-MMP regulation confers melanoma metastasis

  2025cites this paper
• The Diverse Pathways for Cell Surface MT1-MMP Localization in Migratory Cells

  2025cites this paper
• Potential target within the tumor microenvironment - MT1-MMP

  2025cites this paper
• Targets in the Tumour Matrisome to Promote Cancer Therapy Response

  2024cites this paper
• Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives

  2024cites this paper
• Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironments

  2024cites this paper
• Dynamic changes in B cell subpopulations in response to triple-negative breast cancer development

  2024cites this paper
• Gallbladder cancer-associated genetic variants rs1003349 and rs1004030 regulate MMP14 expression by altering SOX10 and MYB binding sites.

  2023cites this paper
• Proteolytic regulation of a galectin-3/Lrp1 axis controls osteoclast-mediated bone resorption

  2023cites this paper
• A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer

  2023cites this paper
• Anti‐cathepsin D immunotherapy triggers both innate and adaptive anti‐tumour immunity in breast cancer

  2023cites this paper
• Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer

  2023cites this paper
• Research progress on factors affecting the sensitivity of breast cancer to radiotherapy: a narrative review

  2023cites this paper
• Matrix metalloproteinases as therapeutic targets in breast cancer

  2023cites this paper
• MMP11 and MMP17 are potential biomarkers for uterine corpus endometrial carcinoma prognosis

  2023cites this paper
• The extracellular matrix - immune microenvironment crosstalk in cancer therapy: challenges and opportunities.

  2023cites this paper
• Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review

  2023cites this paper
• Substrate derived sequences act as subsite‐blocking motifs in protease inhibitory antibodies

  2023cites this paper
• Macrophages in immunoregulation and therapeutics

  2023cites this paper
• Contribution of MMP14-expressing cancer-associated fibroblasts in the tumor immune microenvironment to progression of colorectal cancer

  2022cites this paper
• Preclinical Platform Using a Triple-negative Breast Cancer Syngeneic Murine Model to Evaluate Immune Checkpoint Inhibitors

  2022cites this paper
• Divergent regulation of basement membrane trafficking by human macrophages and cancer cells

  2022cites this paper
• Dual near‐infrared II laser modulates the cellular redox state of T cells and augments the efficacy of cancer immunotherapy

  2022cites this paper
• Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology

  2022cites this paper
• 3D Collagen Fiber Concentration Regulates Treg Cell Infiltration in Triple Negative Breast Cancer

  2022cites this paper
• Exploiting protease activation for therapy

  2022cites this paper
• Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies

  2021cites this paper
• Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy.

  2021cites this paper
• 3D Extracellular Matrix Regulates the Activity of T Cells and Cancer Associated Fibroblasts in Breast Cancer

  2021cites this paper
• The Role of Matrix Metalloproteinases in Endometriosis: A Potential Target

  2021cites this paper
• Vascular Normalization: A New Window Opened for Cancer Therapies

  2021cites this paper
• Combined Radiochemotherapy: Metalloproteinases Revisited

  2021cites this paper
• LOSS OF ENDOTHELIAL CELL MMP14 REDUCES MELANOMA GROWTH AND METASTASIS BY INCREASING TUMOR VESSEL STABILITY.

  2021cites this paper
• Novel immunotherapy strategies involving matrix metalloproteinase (MMP) family

  2021cites this paper
• MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma

  2021cites this paper
• Metalloproteinases in Ovarian Cancer

  2021cites this paper
• Assay of extracellular matrix degradation and transmigration of chicken peripheral blood mononuclear cells after infection with genotype VII Newcastle disease virus in vitro.

  2021cites this paper
• The Extracellular Matrix and Vesicles Modulate the Breast Tumor Microenvironment

  2020cites this paper
• Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges.

  2020cites this paper
• Single peptides and combination modalities for triple negative breast cancer

  2020cites this paper
• Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance

  2020cites this paper
• EO771, is it a well‐characterized cell line for mouse mammary cancer model? Limit and uncertainty

  2020cites this paper
• Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype

  2020cites this paper
• Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases

  2020cites this paper
• Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice.

  2020cites this paper
• Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy

  2020cites this paper
• Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation

  2020cites this paper
• Vascular and extracellular matrix remodeling by physical approaches to improve drug delivery at the tumor site

  2020cites this paper
• High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.

  2020cites this paper
• Differential Impact of Calcitriol and Its Analogs on Tumor Stroma in Young and Aged Ovariectomized Mice Bearing 4T1 Mammary Gland Cancer

  2020cites this paper
• Biophysical and Epigenetic Regulation of Cancer Stemness, Invasiveness, and Immune Action

  2020cites this paper
• The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma

  2019cites this paper
• Monoclonal antibodies against metzincin targets

  2019cites this paper
• MMP14 predicts a poor prognosis in patients with colorectal cancer.

  2019cites this paper
• Estimation of serum matrix metalloproteinases among patients of oral squamous cell carcinoma

  2019cites this paper
• Reducing proteolytic liability of a MMP‐14 inhibitory antibody by site‐saturation mutagenesis

  2019cites this paper
• The immunological consequences of radiation‐induced DNA damage

  2019influential citation
• Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer

  2019cites this paper
• Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges.

  2019cites this paper
• IFN regulatory factor-8 expression in macrophages governs an antimetastatic program.

  2019cites this paper
• The Expanding Role of MT1-MMP in Cancer Progression

  2019cites this paper
• Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases

  2019cites this paper
• Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation

  2019cites this paper
• Construction and integrated analysis of crosstalking ceRNAs networks in laryngeal squamous cell carcinoma

  2019cites this paper
• Matrix Metalloproteases as Influencers of the Cells’ Social Media

  2019cites this paper
• An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer

  2019cites this paper
• Epitope‐specific affinity maturation improved stability of potent protease inhibitory antibodies

  2018cites this paper
• Use of a novel camelid-inspired human antibody demonstrates the importance of MMP-14 to cancer stem cell function in the metastatic process

  2018cites this paper
• Generation of Highly Selective MMP Antibody Inhibitors.

  2018cites this paper
• MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production

  2018cites this paper
• Macrophage-Dependent Trafficking and Remodeling of the Basement Membrane-Interstitial Matrix Interface

  2018cites this paper
• Association of BCSC-1 and MMP-14 with human breast cancer

  2018cites this paper
• Immunotherapeutic interventions of Triple Negative Breast Cancer

  2018cites this paper
• Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium

  2018cites this paper
• Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives.

  2018cites this paper
• Divergent Matrix-Remodeling Strategies Distinguish Developmental from Neoplastic Mammary Epithelial Cell Invasion Programs.

  2018influential citation
• Tumor-associated macrophages in breast cancer: Innocent bystander or important player?

  2018cites this paper
• Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.

  2017cites this paper
• Research report 2016

  2017cites this paper
• Macrophage biology plays a central role during ionizing radiation-elicited tumor response

  2017cites this paper
• Radiation-induced lung metastasis development is MT1-MMP-dependent in a triple-negative breast cancer mouse model

  2017cites this paper
• Identification of cancer genes that are independent of dominant proliferation and lineage programs

  2017cites this paper
• A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer models

  2017cites this paper
• Clinical Implications of Compounds Designed to Inhibit ECM‐Modifying Metalloproteinases

  2017cites this paper
• A new gallium complex inhibits tumor cell invasion and matrix metalloproteinase MMP-14 expression and activity.

  2017cites this paper
• Candidate immune biomarkers for radioimmunotherapy.

  2017cites this paper
• Translational Research in Breast Cancer

  2017cites this paper
• Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.

  2017cites this paper
• Generation of inhibitory monoclonal antibodies targeting matrix metalloproteinase-14 by motif grafting and CDR optimization.

  2017cites this paper
• Pivotal regulators of tissue homeostasis and cancer: macrophages

  2017cites this paper
• Identification of highly selective MMP‐14 inhibitory Fabs by deep sequencing

  2017cites this paper
• A cerebellar window for intravital imaging of normal and disease states in mice

  2017cites this paper
• Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair.

  2017cites this paper
• The Roles of Matrix Metalloproteinases in Pancreatic Cancer.

  2017cites this paper
• HPMA–Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast Cancer

  2017cites this paper
• Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas

  2016cites this paper
• Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect

  2016cites this paper